ABOUT PAREXEL INTERNATIONAL

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best quality solutions to make every phase of the clinical trial process more efficient.

​With the people, insight and focus on operational excellence, we work With Heart™ every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. This approach continues to earn us recognition industrywide, with Parexel being named “Best Contract Research Organization” in November 2023 by an independent panel for Citeline, “Top CRO to Work With” by investigative sites worldwide in the 2023 WCG CenterWatch Global Site Relationship Benchmark Survey and recipient of the 2023 Society for Clinical Research Sites (SCRS) Eagle Award for advancing the clinical research profession through strong site partnerships. For more information, visit us at www.parexel.com.

INDUSTRY INSIGHTS

CONTACT INFORMATION

Parexel International

2520 Meridian Parkway

Durham, NC 27713, NC 27713

UNITED STATES

Contact: Mark Eberhardt

SOLUTIONS

Review how Parexel's Oncology Site Alliance Network can support the accelerated timelines and flexibility required in early phase oncology studies.

Let us expedite the journey of your treatment from the research phase to the patient, ensuring that life-saving therapies reach those in need as swiftly as possible.

With our consulting team by your side, comprised of over 1,000 dedicated professionals, you can be confident that your treatment’s journey from research to patient care is in expert hands.

Our expertise spans the entire drug development process, navigating challenges posed by globalization, stakeholder engagement, scientific innovation, and payer expectations.

AI offers powerful tools to better manage clinical development. By leveraging AI, we can expedite development timelines, ensuring that new products reach patients more quickly.